Cloud healthcare specialist ClearDATA has announced the conclusion of its series B round of funding to the tune of $14m, expanding its opportunities to provide cloud technology in the health industry.

The company, which describes itself as “exclusively dedicated” to healthcare in the cloud, has a solution which is approved by HIPAA (Health Insurance Portability and Accountability Act) and serves over 300,000 healthcare professionals.

The investors in the second round of funding included usual suspects Excel Venture Management and Norwest Venture Partners, as well as crucially the Merck Global Health Innovation Fund, which is the company’s strategic investor.

Darin Brannan, ClearDATA CEO, said in a statement: “The IT demands on healthcare organisations are greater than ever – and they will continue to grow as big data and analytics take hold in the industry.

“Our investors recognise the escalating need for hosting and services in the cloud that can help …